On the stock market since 2018, it operates in the world of health and science. It has 8,878 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (-1% a year).
If every debt were paid off today, $7.1B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 17% — still a thick cushion, though costs have been eating into it lately.
There is $10.9B in the vault; even if every debt were paid off, $7.1B would remain.
It pays out $0.21 per share each year — regular cash for whoever holds the stock.
Over the last 3 years, sales fell about 3% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The price action doesn’t yet back an upward turn. Council score: 0/10.
On our five-subject report card, LVZPF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: LVZPF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.